These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15180656)

  • 1. Estimating mean response as a function of treatment duration in an observational study, where duration may be informatively censored.
    Johnson BA; Tsiatis AA
    Biometrics; 2004 Jun; 60(2):315-23. PubMed ID: 15180656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A partially parametric estimator of survival in the presence of randomly censored data.
    Klein JP; Lee SC; Moeschberger ML
    Biometrics; 1990 Sep; 46(3):795-811. PubMed ID: 2242415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing propensity scores to estimate causal treatment effects with censored time-lagged data.
    Anstrom KJ; Tsiatis AA
    Biometrics; 2001 Dec; 57(4):1207-18. PubMed ID: 11764262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy).
    Rebeiz AG; Dery JP; Tsiatis AA; O'shea JC; Johnson BA; Hellkamp AS; Pieper KS; Gilchrist IC; Slater J; Muhlestein JB; Joseph D; Kitt MM; Tcheng JE;
    Am J Cardiol; 2004 Oct; 94(7):926-9. PubMed ID: 15464679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating incremental cost-effectiveness ratios and their confidence intervals with differentially censored data.
    Wang H; Zhao H
    Biometrics; 2006 Jun; 62(2):570-5. PubMed ID: 16918922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intention-to-treat analyses for incomplete repeated measures data.
    Hogan JW; Laird NM
    Biometrics; 1996 Sep; 52(3):1002-17. PubMed ID: 8805765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of times to repeated events in two-arm randomized trials with noncompliance and dependent censoring.
    Matsui S
    Biometrics; 2004 Dec; 60(4):965-76. PubMed ID: 15606417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT.
    Akkerhuis KM; Deckers JW; Boersma E; Harrington RA; Stepinska J; Mahaffey KW; Wilcox RG; Lincoff AM; Keltai M; Topol EJ; Califf RM; Simoons ML
    Eur Heart J; 2000 Mar; 21(5):371-81. PubMed ID: 10666351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating treatment effect via simple cross design synthesis.
    Kaizar EE
    Stat Med; 2011 Nov; 30(25):2986-3009. PubMed ID: 21898521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-estimation and artificial censoring: problems, challenges, and applications.
    Joffe MM; Yang WP; Feldman H
    Biometrics; 2012 Mar; 68(1):275-86. PubMed ID: 21950320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjusting for observational secondary treatments in estimating the effects of randomized treatments.
    Zhang M; Wang Y
    Biostatistics; 2013 Jul; 14(3):491-501. PubMed ID: 23349243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation for the optimal combination of markers without modeling the censoring distribution.
    Chiang CT; Huang SY
    Biometrics; 2009 Mar; 65(1):152-8. PubMed ID: 18422791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semiparametric analysis of survival data with left truncation and dependent right censoring.
    Jiang H; Fine JP; Chappell R
    Biometrics; 2005 Jun; 61(2):567-75. PubMed ID: 16011706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bootstrap confidence intervals for medical costs with censored observations.
    Jiang H; Zhou XH
    Stat Med; 2004 Nov; 23(21):3365-76. PubMed ID: 15490430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A semiparametric estimator of the bivariate distribution function for censored gap times.
    de Uña-Álvarez J; Amorim AP
    Biom J; 2011 Feb; 53(1):113-27. PubMed ID: 21259312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonparametric inference in factorial designs with censored data.
    Akritas MG; LaValley MP
    Biometrics; 1996 Sep; 52(3):913-24. PubMed ID: 8805761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weighted estimation of the accelerated failure time model in the presence of dependent censoring.
    Cho Y; Ghosh D
    PLoS One; 2015; 10(4):e0124381. PubMed ID: 25909753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival curve estimation for informatively coarsened discrete event-time data.
    Shardell M; Scharfstein DO; Bozzette SA
    Stat Med; 2007 May; 26(10):2184-202. PubMed ID: 16998829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonparametric inference for median costs with censored data.
    Zhao H; Zuo C; Chen S; Bang H
    Biometrics; 2012 Sep; 68(3):717-25. PubMed ID: 22364557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.